본문 바로가기
주메뉴 바로가기
Immunology
About Us
Core Technology Platforms
Pipeline
INVESTORS
Careers
ENG
KOR
ENG
Shaperon
About Us
Company Overview
Our History
CEO Message
Ethical Management
Organization Chart
Vision
Partners
Directions
Core Technology Platforms
Inflammasome
NanoMab
AIDEN
Publications
Pipeline
Line Up
NuGel
NuCerin
NuSepin
NuPulin
AI-based drug discovery
Papiliximab
Ovizumab
Investors
IR Announcements
IR Library
Disclosure
Press Release
News Room
Media Room
Careers
Corporate Culture & Our People
Recruitment
About Us
Company Overview
Our History
CEO Message
Ethical Management
Organization Chart
Vision
Partners
Directions
Core Technology Platforms
Inflammasome
NanoMab
AIDEN
Publications
Pipeline
Line Up
NuGel
NuCerin
NuSepin
NuPulin
AI-based drug discovery
Papiliximab
Ovizumab
Investors
IR Announcements
IR Library
Disclosure
Press Release
News Room
Media Room
Careers
Corporate Culture & Our People
Recruitment
about us
HOME
about us
Contact
about us
Company Overview
Our History
CEO Message
Ethical Management
Organization Chart
Vision
Partners
Directions
Contact
Head Office /
NanoMab center
AIMCE Center
Non-Clinical R&D center
Hudson Therapeutics, inc.
Head Office /
NanoMab center in Seoul
Suite 218 & 606 Gangnam Ace Tower G9, 174-10 Jagok-ro, Gangnam-gu, Seoul 06373, Korea
Tel. +82 (0)2 6083 8315
AIMCE Center in Seoul
Suite 422 Gangnam Exllu Tower, 172, Jagok-ro, Gangnam-gu, Seoul, Korea
Non-Clinical R&D center in Hong-cheon
A-1A10, Wide River Institute of Immunology, 101, Dabyeonbat-gil, Hwachon-myeon, Hongcheon-gun Gangwon-do 25159, Korea
Hudson Therapeutics, Inc.
15 TW Alexander Drive Durham, NC 27709, USA